Assessment of survival in patients with idiopathic pulmonary fibrosis ...

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary ...

The primary end point was the change in FVC or death at week 52. Secondary end points were the 6-minute walk distance, progression-free survival ...

A survival analysis of idiopathic pulmonary fibrosis in the context

Eighty-one patients (male 55, 68%; age 71.4 ± 10.2 years) with IPF received antifibrotic therapy (nintedanib 44.4%; pirfenidone 55.6%; mean follow-up 35 ± 16.5 ...

PREDICTING LONG-TERM SURVIVAL IN PATIENTS WITH ...

PURPOSE: Idiopathic pulmonary fibrosis (IPF) is associated with high mortality, but its prognosis is variable. We used data from the IPF-PRO Registry to ...

Can We Predict the Survival of Idiopathic Pulmonary Fibrosis ...

Interestingly, the clinical course of IPF is variable, with some patients deteriorating rapidly and others remaining in a relatively stable condition. The ...

Assessment of survival in patients with idiopathic pulmonary fibrosis ...

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of 3-5 years after diagnosis with limited treatment ...

Impairments and prognostic factors for survival in patients with ...

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis ...

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary ...

BACKGROUND: Conducting an adequately powered survival study in idiopathic pulmonary fibrosis (IPF) is challenging due to the rare nature of ...

Cluster analysis and survival in patients with Idiopathic pulmonary ...

Background: Idiopathic pulmonary fibrosis (IPF) is a debilitating disease with a heterogeneous disease course that is difficult to predict.

Prognosis and monitoring of idiopathic pulmonary fibrosis - UpToDate

Outline · Combined pulmonary fibrosis and emphysema · Cardiovascular disease · Pulmonary hypertension · Lung malignancy · Obstructive sleep apnea.

New prognostic scoring system for mortality in idiopathic pulmonary ...

Idiopathic pulmonary fibrosis (IPF) is a typical and progressive chronic fibrosing interstitial lung disease (ILD) with a highly variable clinical course and ...

Cohort study to evaluate prognostic factors in idiopathic pulmonary ...

In conclusion, the median survival of IPF patients after starting oxygen therapy is only about 1.5 years. Multivariable analysis at the time ...

Prognosis and Survival in Idiopathic Pulmonary Fibrosis in the Era of ...

The study showed a high mortality for all causes and risk AE in both treated and never-treated patients; in particular, the probability of death and of AE ...

Comparative survival analysis between idiopathic pulmonary ...

146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6–0,8) for CHP group and 0,83 ( ...

Survival benefit of lung transplantation for patients with idiopathic ...

Lung transplantation is effective in improving the survival of selected patients affected by idiopathic pulmonary fibrosis.

Survival and lung function decline in patients with definite, probable ...

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive fibro-proliferative scarring of the lung parenchyma, originating from ...

Rare variants and survival of patients with idiopathic pulmonary ...

Background The clinical course of idiopathic pulmonary fibrosis (IPF) is highly variable and unpredictable, with multiple genetic variants ...

analysis of a pooled cohort from three clinical trials - The Lancet

Mortality is an impractical primary endpoint for clinical trials in patients with idiopathic pulmonary fibrosis who have mild-to-moderate ...

Effect of pulmonary hypertension on survival in patients with ...

Pulmonary hypertension (PH) is a comorbidity associated with idiopathic pulmonary fibrosis (IPF). There is limited research regarding the effect on survival ...

All-cause mortality of patients with idiopathic pulmonary fibrosis

The standardized mortality ratio of IPF patients compared to that of the normal population was 4.66. The leading cause of death in IPF patients ...

The Value of 18 F-FDG PET/CT in Evaluating Disease Severity and ...

Several parameters are useful for assessing disease severity in idiopathic pulmonary fibrosis (IPF); however, the role of 18F-fluorodeoxyglucose ...